Isoform-specific regulation of mood behavior and pancreatic β cell and cardiovascular function by L-type Ca2+ channels

Journal of Clinical Investigation

Volumn 113, Issue 10, 2004, Pages 1430-1439

  Sinnegger Brauns, Martina J ^a   Hetzenauer, Alfred ^a   Huber, Irene G ^a   Renström, Erik ^b   Wietzorrek, Georg ^a   Berjukov, Stanislav ^a   Cavalli, Maurizio ^c   Walter, Doris ^a   Koschak, Alexandra ^a   Waldschütz, Ralph ^d   Hering, Steffen ^a   Bova, Sergio ^c   Rorsman, Patrik ^b   Pongs, Olaf ^d   Singewald, Nicolas ^a   Striessnig, Jörg ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 5 HYDROXYTRYPTOPHAN; CALCIUM CHANNEL L TYPE; DIHYDROPYRIDINE DERIVATIVE; DOPAMINE; GLUTAMIC ACID; NORADRENALIN; CACNA1D PROTEIN, MOUSE; ISOPROTEIN; L TYPE CALCIUM CHANNEL ALPHA(1C); L-TYPE CALCIUM CHANNEL ALPHA(1C);

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BEHAVIOR; BRAIN FUNCTION; BRAIN REGION; CALCIUM CHANNEL L TYPE SUBUNIT CAV1.2; CALCIUM CHANNEL L TYPE SUBUNIT CAV1.3; CALCIUM CURRENT; CARDIOVASCULAR FUNCTION; CHANNEL GATING; CONTROLLED STUDY; CORPUS STRIATUM; EXCITATION CONTRACTION COUPLING; HEART FUNCTION; INOTROPISM; INSULIN RELEASE; LOCOMOTION; MOOD; MOUSE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE CONTRACTILITY; AFFECT; ANIMAL; C57BL MOUSE; DRUG EFFECT; GENETICS; MOUSE MUTANT; PANCREAS ISLET; PHYSIOLOGY; TRANSGENIC MOUSE;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; AFFECT; ANIMALS; CALCIUM CHANNELS, L-TYPE; CARDIOVASCULAR PHYSIOLOGY; DIHYDROPYRIDINES; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN ISOFORMS;

EID: 85047691616     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20208     Document Type: Article

References (53)

1. Hell, J.W., et al. 1993. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel α1 subunits. J. Cell. Biol. 123:949-962.
2. Zakharenko, S.S., Zablow, L., and Siegelbaum, S.A. 2001. Visualization of changes in presynaptic function during long-term synaptic plasticity. Nat. Neurosci. 4:711-717.
3. Deisseroth, K., Mermelstein, P.G., Xia, H., and Tsien, R.W. 2003. Signaling from synapse to nucleus: the logic behind the mechanisms. Curr. Opin. Neurobiol. 13:354-365.
4. 1D (Cav1.3) in area CA1 of the hippocampus and both are ameliorated by chronic nimodipine treatment. Brain Res. Mol. Brain Res. 110:193-202.
5. Mogilnicka, E., Czyrak, A., and Maj, J. 1988. BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine. Eur. J. Pharmacol. 151:307-311.
6. Bauer, E.P., Schafe, G.E., and LeDoux, J.E. 2002. NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J. Neurosci. 22:5239-5249.
7. Miller, R.J. 1987. Multiple calcium channels and neuronal function. Science. 235:46-52.
8. Jinnah, H.A., et al. 2000. Calcium channel agonists and dystonia in the mouse. Mov. Disord. 15:542-551.
9. 2+ channels in pancreatic β cells. Proc. Natl. Acad. Sci. U. S. A. 96:10164-10169.
10. 1D subunit in postnatal pancreatic β cell generation. J. Clin. Invest. 108:1015-1022. doi:10.1172/JCI200113310.
11. 2+ channel mRNAs. J. Mol. Cell. Cardiol. 29:3035-3042.
12. 2+ channels in cardiac pacemaker activity. Proc. Natl. Acad. Sci. U. S. A. 100:5543-5548.
13. Petty, M.A., and Mir, A.K. 1988. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats. Br. J. Pharmacol. 94:1218-1224.
14. 1 subunits. J. Biol. Chem. 276:12730-12735.
15. 2+ channels activating at negative voltages. J. Biol. Chem. 276:22100-22106.
16. 2+ antagonist binding properties and putative folding structure of a recombinant high affinity dihydropyridine binding domain. Biochem. J. 347:829-836.
17. Liu, L., Gonzalez, P.K., Barrett, C.F., and Rittenhouse, A.R. 2003. The calcium channel ligand FPL 64176 enhances L-type but inhibits N-type neuronal calcium currents. Neuropharmacology 45:281-292.
18. Singewald, N., and Sharp, T. 2000. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience. 98:759-770.
19. Franklin, K.B.J., and Paxinos, G. 1997. The mouse brain in stereotaxic coordinates. 1st edition. Academic Press. London, United Kingdom.
20. Singewald, N., Kaehler, S., Hemeida, R., and Philippu, A. 1997. Release of serotonin in the rat locus coeruleus: effects of cardiovascular, stressful and noxious stimuli. Eur. J. Neurosci. 9:556-562.
21. Singewald, N., and Philippu, A. 1993. Catecholamine release in the locus coeruleus is modified by experimentally induced changes in haemodynamics. Naunyn Schmiedebergs Arch. Pharmacol. 347:21-27.
22. Singewald, N., Schneider, C., and Philippu, A. 1994. Effects of neuroactive compounds, noxious and cardiovascular stimuli on the release of amino acids in the rat locus coeruleus. Neurosci. Lett. 180:55-58.
23. Thiele, T.E., Koh, M.T., and Pedrazzini, T. 2002. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 22:RC208.
24. Tschenett, A., et al. 2003. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur. J. Neurosci. 18:143-148.
25. Eller, P., et al. 2000. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. Br. J. Pharmacol. 130:669-677.
26. 2+ channel null mice. EMBO J. 22:3844-3854.
27. Bova, S., et al. 1996. Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature. Br. J. Pharmacol. 117:1041-1046.
28. Bova, S., et al. 1997. Calcium-antagonist effects of norbormide on isolated petfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil. Br. J. Pharmacol. 120:19-24.
29. 2+ channels. Cell. 102:89-97.
30. 2+ channels. Neuroscience. 120:435-442.
31. 2+-dependent inactivation. J. Neurosci. 23:6041-6049.
32. 2+ channels in insulin-secreting mouse pancreatic B cells. Biophys. J. 81:3308-3323.
33. 2+ currents in mouse pancreatic B-cells towards negative potentials. Pflugers Arch. 441:587-595.
34. Jinnah, H.A., et al. 1999. Calcium channel activation and self-biting in mice. Proc. Natl. Acad. Sci. U. S. A. 96:15228-15232.
35. Olive, M.F., Mehmert, K.K., Messing, R.O., and Hodge, C.W. 2000. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. Eur. J. Neurosci. 12:4131-4140.
36. 2+ channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J. Neurosci. 19:6348-6359.
37. Manji, H.K., Drevets, W.C., and Charney, D.S. 2001. The cellular neurobiology of depression. Nat. Med. 7:541-547.
38. Porsolt, R.D., Le Pichon, M., and Jalfre, M. 1977. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:730-732.
39. Cohen, C., Perrault, G., and Sanger, D.J. 1997. Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators. Behav. Pharmacol. 8:629-638.
40. Srivastava, S.K., and Nath, C. 2000. The differential effects of calcium channel blockers in the behavioural despair test in mice. Pharmacol. Res. 42:293-297.
41. Strom, T.M., et al. 1998. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat. Genet. 19:260-263.
42. 2 subunits of a DHP-sensitive calcium channel. Science. 241:1661-1664.
43. Bourson, A., Moser, P.C., Gower, A.J., and Mir, A.K. 1989. Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat. Eur. J. Pharmacol. 160:339-347.
44. Campbell, D.B., North, J.B., and Hess, E.J. 1999. Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Exp. Neurol. 160:268-278.
45. Cain, C.K., Blouin, A.M., and Barad, M. 2002. L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J. Neurosci. 22:9113-9121.
46. Kuzmin, A., Zvartau, E., Gessa, G.L., Martellotta, M.C., and Fratta, W. 1992. Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 41:497-500.
47. Rossetti, Z.L., Isola, D., De Vry, J., and Fadda, F. 1999. Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal. Neuropharmacology. 38:1361-1369.
48. Bonci, A., Grillner, P., Mercuri, N.B., and Bernardi, G. 1998. L-Type calcium channels mediate a slow excitatory synaptic transmission in rat midbrain dopaminergic neurons. J. Neurosci. 18:6693-6703.
49. 2+ channel-mediated short-term plasticity of GABAergic synapses. Nat. Neurosci. 4:975-976.
50. Nesder, E.J., et al. 2002. Neurobiology of depression. Neuron. 34:13-25.
51. Stout, S.C., Mortas, P., Owens, M.J., Nemeroff, C.B., and Moreau, J. 2000. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur. J. Pharmacol. 401:39-46.
52. Salchner, P., and Singewald, N. 2002. Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment. Neuropharmacology. 43:1238-1248.
53. Uchida, S., Yamada, S., Nagai, K., Deguchi, Y., and Kimura, R. 1997. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists. Life Sci. 61:2083-2090.